Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ERIK A COHEN

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1841204435
CMS profile
82786
Location
ALBANY, NY

General Payments · PY2018–2024

$3,214.89

  • Reported across 171 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$667.42

36 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $667.42 36

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Abbott Laboratories $256.37 13
Novo Nordisk AS $173.47 10
ABBVIE INC. $65.61 3
Lilly USA, LLC $59.66 4
SANOFI-AVENTIS U.S. LLC $37.22 2
Amgen Inc. $32.42 2
NOVARTIS PHARMACEUTICALS CORPORATION $23.32 1
RGH ENTERPRISES LLC $19.35 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $237.63 16
PY2019 $150.75 6
PY2020 $79.89 4
PY2021 $485.94 27
PY2022 $682.71 34
PY2023 $910.55 48
PY2024 $667.42 36

Payment records · PY2024 (36)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $8.78 01/05/2024 Food and Beverage Undisputed 01/23/2026 1125297336 CMS
Abbott Laboratories $18.52 01/05/2024 Food and Beverage Undisputed 01/23/2026 1125297338 CMS
Abbott Laboratories $18.52 01/05/2024 Food and Beverage Undisputed 01/23/2026 1125297340 CMS
Abbott Laboratories $17.61 02/26/2024 Food and Beverage Undisputed 01/23/2026 1125297342 CMS
Abbott Laboratories $20.71 04/26/2024 Food and Beverage Undisputed 01/23/2026 1125297344 CMS
Abbott Laboratories $20.71 05/17/2024 Food and Beverage Undisputed 01/23/2026 1125297346 CMS
Abbott Laboratories $20.71 05/17/2024 Food and Beverage Undisputed 01/23/2026 1125297348 CMS
Abbott Laboratories $19.56 07/08/2024 Food and Beverage Undisputed 01/23/2026 1125297350 CMS
Abbott Laboratories $19.55 07/18/2024 Food and Beverage Undisputed 01/23/2026 1125297352 CMS
Abbott Laboratories $21.92 08/07/2024 Food and Beverage Undisputed 01/23/2026 1125297354 CMS
Abbott Laboratories $21.92 11/01/2024 Food and Beverage Undisputed 01/23/2026 1125297356 CMS
Abbott Laboratories $25.00 11/26/2024 Food and Beverage Undisputed 01/23/2026 1125297358 CMS
Abbott Laboratories $22.86 12/11/2024 Food and Beverage Undisputed 01/23/2026 1125297360 CMS
ABBVIE INC. $27.06 03/07/2024 Food and Beverage Undisputed 01/23/2026 1103485873 CMS
ABBVIE INC. $15.80 09/14/2024 Food and Beverage Undisputed 01/23/2026 1103485875 CMS
ABBVIE INC. $22.75 11/22/2024 Food and Beverage Undisputed 01/23/2026 1103485877 CMS
Amgen Inc. $16.21 01/31/2024 Food and Beverage Undisputed 01/23/2026 1111552088 CMS
Amgen Inc. $16.21 11/19/2024 Food and Beverage Undisputed 01/23/2026 1111552090 CMS
Lilly USA, LLC $16.15 02/28/2024 Food and Beverage Undisputed 01/23/2026 1136164218 CMS
Lilly USA, LLC $14.50 03/18/2024 Food and Beverage Undisputed 01/23/2026 1134968083 CMS
Lilly USA, LLC $14.76 03/19/2024 Food and Beverage Undisputed 01/23/2026 1134968085 CMS
Lilly USA, LLC $14.25 04/25/2024 Food and Beverage Undisputed 01/23/2026 1134973933 CMS
Novartis Pharmaceuticals Corporation $23.32 05/23/2024 Food and Beverage Undisputed 01/23/2026 1086770823 CMS
Novo Nordisk Inc $18.81 01/25/2024 Food and Beverage Undisputed 01/23/2026 1097313512 CMS
Novo Nordisk Inc $15.72 02/28/2024 Food and Beverage Undisputed 01/23/2026 1097270554 CMS
Novo Nordisk Inc $21.40 04/10/2024 Food and Beverage Undisputed 01/23/2026 1096761252 CMS
Novo Nordisk Inc $19.27 05/03/2024 Food and Beverage Undisputed 01/23/2026 1096852136 CMS
Novo Nordisk Inc $17.08 06/18/2024 Food and Beverage Undisputed 01/23/2026 1097527111 CMS
Novo Nordisk Inc $15.90 06/25/2024 Food and Beverage Undisputed 01/23/2026 1096644615 CMS
Novo Nordisk Inc $4.79 07/20/2024 Food and Beverage Undisputed 01/23/2026 1097363838 CMS
Novo Nordisk Inc $16.90 09/10/2024 Food and Beverage Undisputed 01/23/2026 1097640486 CMS
Novo Nordisk Inc $16.08 10/31/2024 Food and Beverage Undisputed 01/23/2026 1097376858 CMS
Novo Nordisk Inc $27.52 12/11/2024 Food and Beverage Undisputed 01/23/2026 1097335397 CMS
RGH Enterprises LLC $19.35 05/16/2024 Food and Beverage Undisputed 01/23/2026 1100562638 CMS
SANOFI-AVENTIS U.S. LLC $22.16 05/08/2024 Food and Beverage Undisputed 01/23/2026 1139678171 CMS
SANOFI-AVENTIS U.S. LLC $15.06 10/16/2024 Food and Beverage Undisputed 01/23/2026 1139678329 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.